Showing 1 - 10 of 7,364
Background: Active Pharmaceutical Ingredient (API) manufacturing is an important segment of the Indian pharma industry. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However, India depends heavily on the import of several raw...
Persistent link: https://www.econbiz.de/10012547902
Persistent link: https://www.econbiz.de/10012013562
pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel …
Persistent link: https://www.econbiz.de/10011949028
Does investment in social infrastructure affect the productivity of manufacturing firms in developing countries? To … productivity using firm level data from Pakistan. I split my sample into rural and urban regions to capture the effect of regional … significantly related to firm level productivity in manufacturing industries in Pakistan. However, these results hold for urban …
Persistent link: https://www.econbiz.de/10011456977
Does investment in social infrastructure affect the productivity of manufacturing firms in developing countries? To … productivity using firm level data from Pakistan. I split my sample into rural and urban regions to capture the effect of regional … significantly related to firm level productivity in manufacturing industries in Pakistan. However, these results hold for urban …
Persistent link: https://www.econbiz.de/10012993089
Does investment in social infrastructure affect the productivity of manufacturing firms in developing countries? To … productivity using firm level data from Pakistan. I split my sample into rural and urban regions to capture the effect of regional … significantly related to firm level productivity in manufacturing industries in Pakistan. However, these results hold for urban …
Persistent link: https://www.econbiz.de/10014127605
Persistent link: https://www.econbiz.de/10013163669
Persistent link: https://www.econbiz.de/10014266802
Persistent link: https://www.econbiz.de/10013165172
Understanding the drivers of market concentration in the generic pharmaceutical industry is essential to guaranteeing the availability of low-cost generics. In this paper, we develop a structural model to capture the multiple determinants governing manufacturers' entry decisions; in particular,...
Persistent link: https://www.econbiz.de/10012852626